Healthcare provider profile · identity verified

Douglas Alan Saunders, MD

Internal Medicine · CINCINNATI, OH · NPI 1760473532

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	947	269
Levothyroxine Sodium	Levothyroxine Sodium	395	84
Amlodipine Besylate	Amlodipine Besylate	393	110
Lisinopril	Lisinopril	367	99
Metoprolol Succinate	Metoprolol Succinate	282	73
Pantoprazole Sodium	Pantoprazole Sodium	257	76
Rosuvastatin Calcium	Rosuvastatin Calcium	192	63
Losartan Potassium	Losartan Potassium	175	47
Omeprazole	Omeprazole	172	42
Metformin Hcl	Metformin Hcl	165	49
Sertraline Hcl	Sertraline Hcl	143	41
Metformin Hcl Er	Metformin Hcl	142	40
Gabapentin	Gabapentin	138	22
Tamsulosin Hcl	Tamsulosin Hcl	138	46
Eliquis	Apixaban	123	27
Trazodone Hcl	Trazodone Hcl	120	13
Simvastatin	Simvastatin	118	35
Furosemide	Furosemide	117	32
Pravastatin Sodium	Pravastatin Sodium	109	19
Diclofenac Sodium	Diclofenac Sodium	97	33
Citalopram Hbr	Citalopram Hydrobromide	94	12
Hydrochlorothiazide	Hydrochlorothiazide	91	25
Meloxicam	Meloxicam	91	43
Doxycycline Monohydrate	Doxycycline Monohydrate	90	76
Ezetimibe	Ezetimibe	87	30
Clopidogrel	Clopidogrel Bisulfate	85	27
Albuterol Sulfate Hfa	Albuterol Sulfate	82	32
Methylprednisolone	Methylprednisolone	77	72
Synthroid	Levothyroxine Sodium	76	20
Oxybutynin Chloride Er	Oxybutynin Chloride	72	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	70	22
Ozempic	Semaglutide	70	suppressed
Allopurinol	Allopurinol	65	18
Farxiga	Dapagliflozin Propanediol	59	11
Trulicity	Dulaglutide	59	13
Alendronate Sodium	Alendronate Sodium	56	24
Mirtazapine	Mirtazapine	56	suppressed
Hydralazine Hcl	Hydralazine Hcl	53	12
Jardiance	Empagliflozin	53	14
Ramipril	Ramipril	52	11
Metoprolol Tartrate	Metoprolol Tartrate	51	15
Duloxetine Hcl	Duloxetine Hcl	50	15
Lamotrigine	Lamotrigine	46	suppressed
Potassium Chloride	Potassium Chloride	46	14
Spironolactone	Spironolactone	46	12
Carvedilol	Carvedilol	45	11
Mounjaro	Tirzepatide	42	suppressed
Atenolol	Atenolol	41	11
Donepezil Hcl	Donepezil Hcl	40	15
Pregabalin	Pregabalin	39	suppressed
Valsartan	Valsartan	39	15
Lorazepam	Lorazepam	38	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	38	30
Tramadol Hcl	Tramadol Hcl	38	suppressed
Montelukast Sodium	Montelukast Sodium	37	15
Januvia	Sitagliptin Phosphate	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	18
Famotidine	Famotidine	33	12
Klor-Con M20	Potassium Chloride	33	suppressed
Torsemide	Torsemide	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	13
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Folic Acid	Folic Acid	26	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Prednisone	Prednisone	23	20
Glipizide Er	Glipizide	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	14
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	14
Praluent Pen	Alirocumab	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Diazepam	Diazepam	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Finasteride	Finasteride	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error